Delivery Order SPE2DB24D1007-SPE2DB25FCCLN
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Varivax vaccine with diluents, with a ceiling value of $2,106.02 and an ultimate completion date of November 20, 2025. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded contract under the company's existing indefinite delivery vehicle with DLA. The place of performance is listed as Conshohocken, Pennsylvania, which...
- The Defense Logistics Agency awarded a $94,770.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Varivax vaccine with diluents. The contract, which is classified as a child delivery order under a larger indefinite delivery vehicle, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. This award was made through open competition with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Varivax vaccine with diluents, valued at $2,064.22. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 25, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Varivax vaccine with diluents, with a ceiling value of $11,353.21. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for ultimate completion on September 17, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $82,568.80 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents on August 28, 2025, with an ultimate completion date of September 19, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procurement procedures. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Varivax vaccine with diluents, with a ceiling value of $5,160.55 and a completion date of September 17, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Varivax vaccine with diluents, with a ceiling value of $2,085.12 and an ultimate completion date of September 30, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Varivax vaccine with diluents, valued at $7,297.92. This firm fixed-price delivery order is scheduled for completion by September 18, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation, reflecting the contractor's established capability to meet federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 13, 2025, for the supply of Varivax vaccine with diluents, valued at $21,060.20. This competitively awarded, firm fixed-price delivery order is set to be completed by October 3, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's existing Indefinite Delivery...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Varivax vaccine with diluents, with a ceiling value of $10,321.10. This firm fixed-price delivery order is scheduled for completion by August 25, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was applied to this competitive award. This delivery order is issued under AmerisourceBergen...
- SPE2DB24D1007Indefinite Delivery Contract
- SPE2DB24D1007-SPE2DB25FCCLNDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Varivax vaccine with diluents, with a ceiling value of $1,052.96 and an ultimate completion date of August 4, 2025. This firm fixed-price delivery order, issued under a non-set-aside competition, represents a routine pharmaceutical procurement through DLA's medical supply chain. The place of performance is located at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive IDC serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products, vaccines, and medical supplies to support military healthcare programs worldwide. The company's federal contract portfolio demonstrates established capability to meet competitive procurement requirements across multiple therapeutic domains, serving defense and veteran healthcare systems through both routine and specialized medical commodity deliveries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 7/14/25 |